BioLargo’s Clyra Medical enters sales, distribution agreements

BioLargo (BLGO) announced that its subsidiary Clyra Medical Technologies has entered into a series of agreements to advance the sales and distribution of its medical products in the U.S. and abroad. Although none of the agreements require minimum product purchases, each agreement has the potential to generate material revenue for Clyra.